Serum Institute of India Chief Executive Officer Adar Poonawalla said on Wednesday that the availability of the cervical cancer vaccine will be little in number in 2023. Speaking of the rollout of the cervical cancer vaccines, Adar Poonawalla said the vaccines would be rolled out through government programmes this year. The first made-in-India Human Papillomavirus "CERVAVAC" vaccine, for the prevention …
On the occasion of National Girl Child Day, the Serum Institute of India on Tuesday launched the first indigenously developed human papillomavirus vaccine -- “CERVAVAC,” against the cervical cancer in women. “On the occasion of India’s National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our …
Initially, the vaccine will be made available through the government channel and from next year onwards some private partners would be involved too New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an affordable price range of Rs …
)